GALT Antibody

Code CSB-PA009226LA01HU
Size US$166
Order now
Image
  • Immunohistochemistry of paraffin-embedded human tonsil tissue using CSB-PA009226LA01HU at dilution of 1:100

  • Immunohistochemistry of paraffin-embedded human adrenal gland tissue using CSB-PA009226LA01HU at dilution of 1:100

  • Western Blot
    Positive WB detected in: Rat liver tissue, Mouse kidney tissue
    All lanes: GALT antibody at 3µg/ml
    Secondary
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 44, 32 kDa
    Observed band size: 44 kDa

  • Immunofluorescent analysis of Hela cells using CSB-PA009226LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)

  • Immunoprecipitating GALT in HepG2 whole cell lysate
    Lane 1: Rabbit control IgG instead of CSB-PA009226LA01HU in HepG2 whole cell lysate. For western blotting, a HRP-conjugated Protein G antibody was used as the secondary antibody (1/2000)
    Lane 2: CSB-PA009226LA01HU (8µg) + HepG2 whole cell lysate (500µg)
    Lane 3: HepG2 whole cell lysate (10µg)

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) GALT Polyclonal antibody
Uniprot No.
Target Names
GALT
Alternative Names
Gal 1 P uridylyltransferase antibody; Gal-1-P uridylyltransferase antibody; Galactose 1 phosphate uridyl transferase antibody; Galactose 1 phosphate uridylyltransferase antibody; Galactose-1-phosphate uridylyltransferase antibody; GALT antibody; GALT_HUMAN antibody; UDP glucose hexose 1 phosphate uridylyltransferase antibody; UDP-glucose--hexose-1-phosphate uridylyltransferase antibody
Raised in
Rabbit
Species Reactivity
Human, Mouse, Rat
Immunogen
Recombinant Human Galactose-1-phosphate uridylyltransferase protein (1-379AA)
Immunogen Species
Homo sapiens (Human)
Conjugate
Non-conjugated

The GALT Antibody (Product code: CSB-PA009226LA01HU) is Non-conjugated. For GALT Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA009226LB01HU GALT Antibody, HRP conjugated ELISA
FITC CSB-PA009226LC01HU GALT Antibody, FITC conjugated
Biotin CSB-PA009226LD01HU GALT Antibody, Biotin conjugated ELISA
Clonality
Polyclonal
Isotype
IgG
Purification Method
>95%, Protein G purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form
Liquid
Tested Applications
ELISA, WB, IHC, IF, IP
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:5000
IHC 1:20-1:200
IF 1:50-1:200
IP 1:200-1:2000
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Description

The GALT polyclonal antibody was produced in three stages: first, a rabbit was immunized with the recombinant human Galactose-1-phosphate uridylyltransferase protein (1-379aa); then, antibodies were collected and isolated from the rabbit serum; and finally, the resulting antibodies were purified via protein G affinity chromatography.

This GALT polyclonal antibody contains few impurities, with a purity of over 95%. It is capable of detecting and binding to GALT protein from human, mouse, and rat samples. Its versatility has been demonstrated through successful implementation in various applications, including ELISA, WB, IHC, IF, and IP, indicating its effectiveness in diverse experimental contexts.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Plays an important role in galactose metabolism.
Gene References into Functions
  1. GALT mutation is associated with galactosemia. PMID: 29252199
  2. The mutational spectrum of the GALT gene in Greek galactosemia patients is presented for the first time. PMID: 28644047
  3. novel splicing mutation in GALT gene causing Galactosemia in Ecuadorian family PMID: 28450132
  4. 17 VUS (37%; 7 in ACADM, 9 in GALT, and 1 in PAH) were reclassified from uncertain (6 to benign or likely benign and 11 to pathogenic or likely pathogenic). We identified common types of missing information that would have helped make a definitive classification and categorized this information by ease and cost to obtain PMID: 27308838
  5. we present the 1.9 A resolution crystal structure of human GALT (hGALT) ternary complex, revealing a homodimer arrangement that contains a covalent uridylylated intermediate and glucose-1-phosphate in the active site, as well as a structural zinc-binding site, per monomer PMID: 27005423
  6. A novel noncoding homozygous GALT variant associated with asymptomatic galactosemia has been described in an infant of consanguineous heterozygous parents. PMID: 25920691
  7. Mutation activates a cryptic donor splice site, inducing an aberrant splicing of the GALT pre-mRNA, which in turn leads to a frameshift with inclusion of a premature stop codon. PMID: 25052314
  8. GALT activity in red blood cells of patients with galactosaemia PMID: 25268296
  9. Novel missense mutations identified in Italian galactosemic patients. PMID: 25592817
  10. In Korean population, novel GALT mutations were identified in the galactosemia patients different from those of other populations. PMID: 25124065
  11. suggests that GALT mutations are ethnic-specific and that galactosemia is a heterogeneous disorder at the molecular level PMID: 24045215
  12. In this report, we present GALT gene mutations in 56 cases of galactosemia from Turkey identified using DNA microarray resequencing. PMID: 23924834
  13. Data suggest that in classic galactosemia residual GALT activity (predicted from activity of recombinant GALT matching patient's mutation) correlates with reduced ovarian reserve (as indicted by biological marker, circulating anti-Mullerian hormone). PMID: 23690308
  14. HGALT requires a level of flexibility to function optimally and that altered folding is the underlying reason of impairment in all the variants tested here. PMID: 23583749
  15. The study determined the frequency of the two most common GALT mutations and their variants in Indian galactosemia patients. PMID: 22798028
  16. The novel GALT gene mutations included 6 missense mutations viz. Y89H, Q103R, P166A, S181F, K285R, R333L; one nonsense mutation, S307X and 3 silent mutations--Q103Q, K210K and H319H. PMID: 23022339
  17. Forty four novel variations in the GALT gene were identified, among them 27 nucleotide substitutions, in the French cohort of galactosemic patients. PMID: 22944367
  18. Mutations of the galactose-1-phosphate uridyltranseferase gene is associated with galactosemia. PMID: 22963887
  19. Duarte1 (D1) and D2 genotypes of GALT do not appear to play a role in the association between galactose intake, possible ovarian dysfunction, and the link with ovarian cancer PMID: 22749219
  20. 3 different GALT mutations viz. Q188R, N314D and S307X were found to be present in the family of a neonate diagnosed with galactosemia and having the heterozygote genotype Q188R/S307X. S307X is a novel GALT mutation linked to galactosemia. PMID: 21188552
  21. Results suggest that classical galactosaemia shows low allelic heterogeneity in Mexican patients. PMID: 18956253
  22. Congenital eye abnormalities and galactosemia were found in a family with Q188R and G1391A mutations. PMID: 20222886
  23. GALT deletion mutation carrier frequency was 1 in 127 (0.79%). PMID: 21059483
  24. live birth incidence of classical galactosemia in Estonia is 1:19.700 PMID: 20151200
  25. The simulated point mutations have a direct effect on the active site, or on the dimer assembly and stability, or on the monomer stability. PMID: 20008339
  26. no effect seen of N314D GALT genotype on risk of borderline or invasive ovarian cancer PMID: 11936817
  27. Data found no association between congenital absence of the uterus and vagina (CAUV) and the N314D allele of the galactose-1-phosphate uridyl transferase (GALT) gene. PMID: 12606594
  28. Increased expression of Galactosyltransferase is associated with ovarian cancer PMID: 12851678
  29. association of decreased galactose-1-phosphate uridyltransferase activity with idiopathic presenile cataract PMID: 14707519
  30. children and adolescents with galactosemia function generally within the low average IQ range and have less well-developed executive functions. PMID: 15506833
  31. No statistically significant differences were observed in the allele frequencies between the infertile women and control groups for GALT PMID: 15749517
  32. Nine novel mutations in the GALT gene associated with Classical galctosemia are described. PMID: 15841485
  33. No association of GALT mutations is found in 86 patients with idiopathic premature ovarian failure. PMID: 16009197
  34. We postulate that molecular link between defective GALT enzyme, which result in classic galactosemia and the cerebroside galactosyl transferase, responsible for galactosylation of cerebrosides, is dependent on concentrations of UDP-galactose. PMID: 16125333
  35. no relationship was found between ovarian failure and GALT polymorphisms in Indian women PMID: 16274605
  36. no significant differences between women carrying at least one N314D or Q188R GALT allele and controls in IVF outcomes measured: numbers of follicles and oocytes obtained; fertilization rates and percentage of Grade A embryos; and pregnancy rates. PMID: 16595241
  37. analysis of classical galactosaemia mutations in GALT1 in Spain and Portugal PMID: 17041746
  38. analysis of a patient with galactose-1-phosphate uridyltransferase mutations p.Q188R and p.R333W and galactose metabolite levels during breast-feeding [case report] PMID: 17143577
  39. Identified novel mutations in GALT gene using DNA testing. PMID: 17876724
  40. The R204X mutation severely compromises both expression and function of human GALT;T268N is one of a very small number of naturally occurring rare but neutral missense polymorphisms in human GALT. PMID: 18210213
  41. Synergistic effect of GALT and lactase mutations on cataract formation. PMID: 18454942
  42. 4 bp 5' deletion in GALT is a causal mutation in Duarte galactosemia. PMID: 19224951
  43. Galactose-1-phosphate uridyl transferase deficiency is not associated with Mullerian aplasia in Dutch patients PMID: 19646668

Show More

Hide All

Involvement in disease
Galactosemia (GALCT)
Protein Families
Galactose-1-phosphate uridylyltransferase type 1 family
Database Links

HGNC: 4135

OMIM: 230400

KEGG: hsa:2592

STRING: 9606.ENSP00000368119

UniGene: Hs.522090

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*